<DOC>
	<DOCNO>NCT00862693</DOCNO>
	<brief_summary>Immunoglobulin A ( IgA ) nephropathy common primary glomerulonephritis world . Much literature suggest vitamin D analog profound effect immune system function glomerular mesangial cell proliferation . Therefore , investigator plan conduct randomized clinical study evaluate efficacy Calcitriol treatment IgA nephropathy . Forty patient biopsy-proven IgA nephropathy recruit . They randomize Calcitriol six month treatment . Proteinuria , renal function , serum urinary inflammatory marker monitor . This study explore potential anti-proteinuric anti-inflammatory effect Calcitriol treatment IgA nephropathy , specific treatment present .</brief_summary>
	<brief_title>Calcitriol Treatment Immunoglobulin A Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Glomerulonephritis</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin A</mesh_term>
	<criteria>Aged 1865 year Biopsyconfirmed IgA nephropathy Proteinuria &gt; 0.8 g/day 3 consecutive sample within 12 week despite ACE inhibitor angiotensin receptor blocker treatment least 3 month estimate glomerular filtration rate &lt; 60 ml/min/1.73m2 Corrected serum calcium level &lt; = 2.45 mmol/l Willingness give write consent comply study protocol Pregnancy , lactate childbearing potential without effective method birth control Severe gastrointestinal disorder interfere ability receive absorb oral medication History malignancy , include leukemia lymphoma within past 2 year Systemic infection require therapy study entry Any severe coexisting disease , limited , chronic liver disease , myocardial infarction , cerebrovascular accident , malignant hypertension History drug alcohol abuse within past 2 year Participation previous trial paricalcitol Patients receive treatment vitamin D and/or analogue medical reason within past 3 month Patients receive treatment corticosteroid On investigational drug within last 30 day History psychological illness condition interfere patient 's ability understand requirement study History noncompliance Known history sensitivity allergy paricalcitol vitamin D analog</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Immunoglobulin A</keyword>
	<keyword>Antibodies</keyword>
	<keyword>treatment</keyword>
</DOC>